Formulating the future of biologics.
Elektrofi is a biopharmaceutical formulation technology company revolutionizing the delivery of biologic therapies by enabling subcutaneous administration of medicines traditionally given intravenously. Using its proprietary Hypercon microparticle platform, Elektrofi partners with biopharmaceutical companies to develop hyper-concentrated, stable formulations of monoclonal antibodies and therapeutic proteins, giving patients more convenient treatment options.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountOct 2025
Oct 2024
Jun 2022
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Global biosimulation software and services company accelerating drug development for 2,000+ bioph...
